Additionally, we have created additional Norovirus GI.1 and GII.4 constructs that we believe based on preclinical data may be more potent than the constructs being evaluated in clinical trials. We are ...

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies London ...

The London-based left-leaning newspaper recently offered staffers free mental health counseling to cope with President-elect ...

Cardinal Health CAH recently announced that it has entered into definitive agreements to acquire two companies. These agreements are likely to accelerate Cardinal Health's strategic growth areas along ...

During a press conference for the upcoming filmAbout Family on November 12th at Lotte Cinema Konkuk University in Seoul, Lee ...

Cardinal's (NYSE:CAH) stock had topped records for the previous three days of ... The deals, expected to close early in 2025 ...

Large amounts of sugar can damage cells, causing chronic inflammation, which can lead to obesity, heart disease, diabetes, ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...

The company will buy a majority stake in GI Alliance (GIA), the a gastroenterology management services organization, from a ...

Cardinal Health noted that it will acquire a majority stake in GI Alliance (GIA), the country's leading gastroenterology (GI) management services organization (MSO), from a combination of GIA ...